Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). (Q44774860)
scientific article published on 23 February 2004
Language:
Current Data About Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN).
(P31) (Q13442814)
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

(P304) 1188-1194
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

(P407) (Q1860)

(P433) 7
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

(P478) 22
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

(P577) Monday, February 23, 2004
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

(P921) (Q194908)

(Q18556333)
(P887)

(Q1164529)
(P887)

(P1433) (Q400292)
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

(P1476) "Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)." (language: en)
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

(P2093) J Atzpodien
(P1545) 1
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

H Kirchner
(P1545) 2
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

U Jonas
(P1545) 3
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

L Bergmann
(P1545) 4
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

H Schott
(P1545) 5
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

H Heynemann
(P1545) 6
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

P Fornara
(P1545) 7
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

S A Loening
(P1545) 8
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

J Roigas
(P1545) 9
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

S C Müller
(P1545) 10
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

H Bodenstein
(P1545) 11
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

S Pomer
(P1545) 12
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

B Metzner
(P1545) 13
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

U Rebmann
(P1545) 14
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

R Oberneder
(P1545) 15
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

M Siebels
(P1545) 16
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

T Wandert
(P1545) 17
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

T Puchberger
(P1545) 18
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

M Reitz
(P1545) 19
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)
(P1545) 20
(P248)
(P698) 14981107
(P813) Wednesday, December 6, 2017

other details
description scientific article published on 23 February 2004

External Links
(P356) 10.1200/JCO.2004.06.155
(P698) 14981107